A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Bioaffinity Technologies Inc W stock. As of the latest transaction made, Citadel Advisors LLC holds 39,180 shares of BIAFW stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,180
Previous 22,221 76.32%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
N/A
16,959 Added 76.32%
39,180 $0
Q2 2024

Aug 14, 2024

SELL
N/A
-1,959 Reduced 8.1%
22,221 $0
Q1 2024

May 15, 2024

SELL
N/A
-201 Reduced 0.82%
24,180 $0
Q4 2023

Feb 14, 2024

SELL
N/A
-1,337 Reduced 5.2%
24,381 $0
Q3 2023

Nov 14, 2023

SELL
N/A
-2,823 Reduced 9.89%
25,718 $0
Q2 2023

Aug 14, 2023

BUY
N/A
13,304 Added 87.31%
28,541 $0
Q1 2023

May 15, 2023

BUY
N/A
15,237 New
15,237 $0

Others Institutions Holding BIAFW

About BIOAFFINITY TECHNOLOGIES INC W


  • Ticker BIAFW
More about BIAFW
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.